![CHEMORADIATION IN CANCER THERAPY](https://d3525k1ryd2155.cloudfront.net/f/281/290/9781588290281.IN.0.m.jpg)
Stock Photo: Cover May Be Different
CHEMORADIATION IN CANCER THERAPY Hardcover - 2003
by CHOY, HAK ,
- New
- Hardcover
- first
Description
New
NZ$101.00
NZ$16.56
Shipping to USA
Standard delivery: 7 to 12 days
More Shipping Options
Standard delivery: 7 to 12 days
Ships from DELHI BOOK STORE (India)
About DELHI BOOK STORE India
Biblio member since 2007
Our prime concern is to make books available with its extensive choices of titles on all subjects for medicine, engineers, technocrats, corporates, scientists, academics, students, scholars and many more at attractive price range.
Details
- Title CHEMORADIATION IN CANCER THERAPY
- Author CHOY, HAK ,
- Binding Hardcover
- Edition 1st
- Condition New
- Pages 420
- Volumes 1
- Language ENG
- Publisher Humana Press, USA
- Date 2003
- Illustrated Yes
- Features Bibliography, Illustrated, Index
- Bookseller's Inventory # AME_9781588290281
- ISBN 9781588290281 / 158829028X
- Weight 2.13 lbs (0.97 kg)
- Dimensions 10 x 7 x 0.94 in (25.40 x 17.78 x 2.39 cm)
- Library of Congress subjects Neoplasms - drug therapy, Cancer - Chemotherapy
- Library of Congress Catalog Number 2002027347
- Dewey Decimal Code 616.994
First line
The medical uses of ionizing radiation have expanded dramatically since Wilhelm Roentgen first discovered it at the end of the last century.
From the rear cover
The combination of chemotherapeutic drugs and radiation to treat solid tumors has now become a common treatment option in many clinical settings. In Chemoradiation in Cancer Therapy, internationally recognized experts in cancer biology and clinical research review the present status of these multimodality approaches to the management of solid tumors and speculate on possible future strategies for their use. As part of their comprehensive survey, the authors detail applications of combined modality therapy in lung, esophageal, breast, gastric, pancreatic, colon, and rectal cancers. They also show how radiation interacts with such chemotherapeutic agents as the platinum complexes, taxanes, and gemcitabine in the treatment of malignant gliomas, and head and neck cancer. Rounding out the presentation is a review of how to integrate new specific molecular-targeted agents into future multimodality therapy. Here the discussion centers on the antibody for the epidermal growth factor receptor (EGFR), antiangiogenesis agents, farnesyltransferase inhibitors (FTIs), gene therapies, and signaling pathway inhibitors in combination with radiotherapy, and with or without classical chemotherapeutic agents.
State-of-the-art and forward-looking, Chemoradiation in Cancer Therapy offers oncologists a thorough understanding of today's best current and future strategies available for the treatment of solid tumors by chemoradiation therapy.
State-of-the-art and forward-looking, Chemoradiation in Cancer Therapy offers oncologists a thorough understanding of today's best current and future strategies available for the treatment of solid tumors by chemoradiation therapy.